Five percent of adults, or about 10 million Americans have a serious mental illness, such as schizophrenia, major depression or bipolar disorder. National Alliance on Mental Illness
Biennial Educational Conference
Anxiety in Children, Teens and Young Adults: Cutting Edge Research and Treatment
- Friday, November 4, 2011, 8:15 AM
- Oakland Schools Conference Center, Waterford
- 2111 Pontiac Lake Road | Waterford, MI 48328 | 248.209.2500
- Keynote Speaker – Daniel Pine, MD
- “Anxiety in Children, Teens and Young Adults”
- Regular Fee $55 | *Student Fee $45 Please send a copy of student ID with registration
Dr. Daniel Pine is a child psychiatrist who has worked at Columbia University and the National Institute of Health (NIH). His areas of expertise include biological and pharmacological aspects of mood, anxiety and behavioral disorders in children, as well as classification of psychopathology across the lifespan. Dr. Pine also possesses expertise in the biological commonalities and differences among psychiatric disorders of children, adolescents and adults as well as on interfaces between psychiatric and medical disorders. Currently, his research examines degrees to which mood and anxiety disorders in children and adolescents are associated with abnormalities in the brain. Dr. Pine has received many awards, including research awards from the American Academy of Child and Adolescent Psychiatry, the American College of Neuropsychopharmacology, the NIH and the American Psychiatric Association.
The goals of this program are to teach participants about the diagnosis, pathophysiology and course of pediatric (infancy to 18 years) and young adult anxiety disorders and to describe current empirically based psychotropic medications and psychotherapeutic treatments for these disorders as well as treatments that are being researched.
Participant Learning Objectives
The participant will be able to describe the diagnostic criteria for pediatric anxiety disorders; explain the pathophysiology and course of pediatric anxiety disorders; utilize current data related to medications and psychotherapies to assist in evaluating the benefits and shortcomings of available evidence-based therapies; identify the similarities and differences among current therapeutic treatment options and describe the variables being considered in researching future possible treatments.
8:00 AM – 8:50 AM Registration / Exhibits
8:50 AM – 9:00 AM Welcome / Introduction – Jeffrey London, MD
9:00 AM – 10:45 AM Session I – Daniel Pine, MD – Pediatric and Young Adult Anxiety Disorders: Diagnosis, Outcome and Pathophysiology
10:45 AM – 11:00 AM Break/Exhibits
11:00 AM – 12:30 PM Session II – Daniel Pine, MD – Pediatric and Young Adult Anxiety Disorders: Current and Future Treatments
12:30 PM – 12:45 PM (Wrap Up – Jeffrey London, MD – Evaluations, CEUs, Exhibits
3 CEUs are approved for social workers.
This course is approved by the Michigan Social Work Continuing Education Collaborative.
.3 SB-CEUs are approved for educators
CEUs are pending for counselors
3 CEs are approved for psychologists.
The Michigan Psychological Association/Foundation is approved by the American Psychological Association to sponsor continuing education for psychologists. The MPA/F maintains responsibility for this program and its content and is a co-sponsor of this conference; CE credits will be available upon completion of the workshop. Certificates of attendance available at registration; those arriving late or leaving early will be unable to secure CEUs.